The Global Cell Culture Market Size is valued at USD 27.48 billion in 2023 cell cultureand is predicted to reach USD 65.13 billion by the year 2031 at a 11.61% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- Continued investment in R&D across the academic, government, and business sectors drives innovation in cell culture technology.
- The global cell culture market is predicted to develop at a substantial rate during the forecast period, owing to increased awareness of the benefits of cell-based vaccines due to the rising prevalence of chronic diseases.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- One of the significant concerns restraining industry growth is complex processes influenced by various factors such as cell type, media composition, environmental conditions, and handling techniques.
The cell culture industry is expected to rise due to improvements in 3D culture technologies and their expanding use in biopharmaceutical manufacturing, drug discovery, and tissue engineering applications. The manufacture of innovative vaccines and biopharmaceuticals has been made possible by recent advancements in gene expression technology, expanding the research & development applications of cell culture techniques. Moreover, the market is anticipated to be driven by increased cancer research programs and an expanding range of gene therapy applications.
Due to the enormous contribution of cell culture technology to developing new diagnostic and treatment options for the COVID-19 pandemic, the demand for items derived from cell culture has increased. Examples of research applications of cell lines that are anticipated to favor market expansion include high-throughput COVID-19 drug screening for discovering new drug candidates and studies aiming at understanding the mechanism of viral entry into host cells. The growth prospects in this field are also increased because culturing techniques provide crucial instruments for creating viral particles for vaccine development.
Recent Developments:
- In May 2023, Lonza introduced the TheraPEAK® T-VIVO Cell Culture Medium, a unique chemically defined medium designed to improve CAR T-cell production. The medium is free of animal-derived components, which increases consistency and process control while also simplifying regulatory approval for a speedier time-to-market.
- In September 2022, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific DynaSpin Single-Use Centrifuge system during the BioProcess International annual conference in Boston, Massachusetts. The technology is specifically intended to provide the best single-use option for large-scale cell culture harvesting. The DynaSpin technology simplifies and optimizes harvesting for cell culture separation in single-use bioprocesses by lowering the number of depth filtering cartridges necessary to finish the harvest process.
Competitive Landscape
Some of the Cell Culture market players are:
- Adolf Kühner AG
- Agilent Technologies, Inc.
- ANGUS Chemical Company
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biospherix Ltd.
- Bio-Techne Corporation
- Caisson Laboratories Inc.
- Cellexus
- Corning Incorporated
- Danaher Corporation
- Eppendorf AG
- FUJIFILM Irvine Scientific, Inc.
- Getinge AB
- HiMedia Laboratories
- InvivoGen
- Lonza Group AG
- Meissner Filtration Products Inc.
- Merck KGaA
- Miltenyi Biotec
- Pan-Biotech GmbH
- PromoCell GmbH
- Sartorius AG
- SeraCare Life Sciences Inc.
- Solida Biotech GmbH
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific, Inc.
- VWR International, LLC
Market Segmentation:
The Cell Culture market is segregated into consumables, products, and applications. Based on consumables, the market is segmented as Media, Minimum Essential Media (MEM), RPMI 1640 Media, MEM/F-12 Media, F-10 Serum-Free Media, BME Media, Insect Media, Other Media, Sera, Fetal Bovine Serum, Other AnimalSerum, Reagents, Albumin, and Other. The product segment includes Culture Systems, Incubators, Centrifuges, Cryostorage Equipment, Biosafety Equipment, and Pipetting Instruments. By application, the market is segmented into Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Toxicity Testing, Cancer Research, and Others.
Based On Consumable, The Media Segment Is Accounted As A Major Contributor In The Cell Culture Market
Due to the substantial demand for media products for use in research and development applications, media accounted for the greatest revenue share. The market penetration for media products has expanded as a result of the availability of a variety of serum- and animal-component-free and customised media alternatives. Also, the commercialization of specialised media for stem cell applications is escalating, which is anticipated to accelerate the segment's expansion. For instance, businesses like Sartorius AG and Thermo Fisher Scientific, Inc. provide media products designed for stem cell culture.
Biopharmaceutical Segment Witness Growth At A Rapid Rate
The segment with the highest revenue share was biopharmaceuticals. The use of cell culture techniques in the production of biopharmaceuticals is predicted to increase as a result of the use of mammalian cell lines, such as the Chinese hamster ovary, and the growing desire for alternative medicines. Furthermore, the recent development of a number of grafting methods and individualized treatment alternatives has increased the growth potential in the biopharmaceutical industry.
In The Region, The North America Cell Culture Market Holds Significant Revenue Share
Due to major investments in R&D, the presence of an established scientific infrastructure, the high demand for media without animal components, and other considerations, North America held the biggest revenue share. In addition, it is anticipated that continued research and the growth of the biopharmaceutical sector in the U.S. will foster industry development in the area. Key firms like Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Becton, Dickinson, and Company can greatly influence the industry if they are present.
Cell Culture Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 27.48 Bn |
|
Revenue forecast in 2031 |
USD 65.13 Bn |
|
Growth rate CAGR |
CAGR of 11.61 % from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Consumables, Products, And Applications |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Cargill Inc., Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; Becton, Dickinson and Company; Merck KGaA; Sartorius AG; VWR International, LLC; Eppendorf SE; PromoCell GmbH; Bio-Techne Corporation; BioSpherix, Ltd. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
